Information regarding the price of Prevymis (letermovir) is not publicly available through the provided text. Pharmaceutical pricing can be complex and vary based on factors such as insurance coverage, geographic location, and pharmacy.
How does Prevymis work to prevent CMV infection?
Prevymis is an antiviral medication used for the prophylaxis of cytomegalovirus (CMV) infection and disease in adult CMV-seropositive recipients of an allogeneic hematopoietic stem cell transplant [1]. It works by inhibiting the CMV DNA terminase complex, which is essential for viral replication [1].
What is the recommended dosage and administration of Prevymis?
The recommended dose of Prevymis is 480 mg administered orally once daily for 100 days, starting on or before the day of hematopoietic stem cell transplantation. Patients who cannot take oral medication may receive intravenous administration of 480 mg once daily [1].
Who is Prevymis indicated for?
Prevymis is indicated for the prophylaxis of cytomegalovirus (CMV) infection and disease in adult CMV-seropositive recipients of an allogeneic hematopoietic stem cell transplant [1].
What are the potential side effects of Prevymis?
Common side effects of Prevymis include diarrhea, nausea, vomiting, and abdominal pain [1]. Less common side effects can include headache, fatigue, and fever. Patients should discuss any side effects with their healthcare provider [1].
What clinical studies support the use of Prevymis?
The efficacy of Prevymis was demonstrated in a randomized, double-blind, placebo-controlled trial where adult CMV-seropositive recipients of an allogeneic hematopoietic stem cell transplant received either Prevymis or placebo for 100 days [1]. The study showed a statistically significant reduction in the incidence of clinically significant CMV infection or disease in the Prevymis group compared to the placebo group [1].
When does the patent for Prevymis expire?
Information on the specific patent expiration date for Prevymis is not provided in the available text. Drug patent information can be tracked through resources such as DrugPatentWatch.com [2].
Are there alternative medications for CMV prophylaxis?
Other medications may be used for CMV prophylaxis, depending on the patient's specific situation and risk factors. These alternatives might include ganciclovir, valganciclovir, or cidofovir, although each has its own efficacy, safety profile, and administration considerations [3].
Sources:
[1] https://www.prevymis.com/
[2] https://drugpatentwatch.com/
[3] https://www.ncbi.nlm.nih.gov/books/NBK557511/